Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,217,000 | 7,701,000 | 7,571,000 | 11,068,000 | 9,918,000 |
| Marketable Securities | 836,000 | 854,000 | 4,273,000 | 1,491,000 | 1,484,000 |
| Receivables | 8,373,000 | 8,432,000 | 9,810,000 | 10,890,000 | 7,709,000 |
| Inventories | 1,909,000 | 2,061,000 | 1,852,000 | 1,682,000 | 1,750,000 |
| Other current assets | 0 | 0 | 0 | 0 | 2,899,000 |
| TOTAL | $20,335,000 | $19,048,000 | $23,506,000 | $25,131,000 | $23,760,000 |
| Non-Current Assets | |||||
| PPE Net | 5,818,000 | 6,089,000 | 6,425,000 | 6,957,000 | 7,307,000 |
| Investments And Advances | 646,000 | 588,000 | 543,000 | 535,000 | 184,000 |
| Intangibles | 26,028,000 | 26,346,000 | 20,842,000 | 22,029,000 | 0 |
| Other Non-Current Assets | 3,072,000 | 1,463,000 | 1,514,000 | 1,475,000 | 23,669,000 |
| TOTAL | $35,564,000 | $34,486,000 | $29,324,000 | $30,996,000 | $31,160,000 |
| Total Assets | $55,899,000 | $53,534,000 | $52,830,000 | $56,127,000 | $54,920,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,788,000 | 901,000 | 1,990,000 | 125,000 | 0 |
| Accounts payable and accrued liabilities | 10,362,000 | 9,221,000 | 8,975,000 | 8,661,000 | 8,687,000 |
| Other current liabilities | 825,000 | 919,000 | 1,397,000 | 1,103,000 | 1,299,000 |
| TOTAL | $16,051,000 | $13,903,000 | $15,752,000 | $16,787,000 | $17,640,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,588,000 | 9,409,000 | 7,338,000 | 9,097,000 | 9,137,000 |
| aiOther Non-Current Liabilities | 5,165,000 | 3,670,000 | 3,506,000 | 3,660,000 | 4,075,000 |
| TOTAL | $16,595,000 | $15,685,000 | $13,612,000 | $15,930,000 | $16,459,000 |
| Total Liabilities | $32,646,000 | $29,588,000 | $29,364,000 | $32,717,000 | $34,099,000 |
| Shareholders' Equity | |||||
| Common Shares | 315,000 | 312,000 | 323,000 | 352,000 | 363,000 |
| Retained earnings | 16,960,000 | 17,955,000 | 17,888,000 | 18,272,000 | 16,198,000 |
| Other shareholders' equity | 1,995,000 | 2,175,000 | 2,177,000 | 2,114,000 | 2,080,000 |
| TOTAL | $23,253,000 | $23,946,000 | $23,466,000 | $23,410,000 | $20,821,000 |
| Total Liabilities And Equity | $55,899,000 | $53,534,000 | $52,830,000 | $56,127,000 | $54,920,000 |